The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nikiforova T.A.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Shchekochikhin D.Iu.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova;
Moskovskiĭ gosudarstvennyĭ universitet im. M.V. Lomonosova

Lomonosova A.A.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Manaa Kh.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Kopylov F.Iu.

Pervyĭ MGMU im. I.M. Sechenova, kafedra profilakticheskoĭ i neotlozhnoĭ kardiologii FPPOV, Moskva

Syrkin A.L.

Sechenov First Moscow State Medical University

Biomarkers role in the first decompensation of chronic heart failure with preserved left ventricular ejection fraction: 2-year follow-up

Authors:

Nikiforova T.A., Shchekochikhin D.Iu., Lomonosova A.A., Manaa Kh., Kopylov F.Iu., Syrkin A.L.

More about the authors

Read: 1226 times


To cite this article:

Nikiforova TA, Shchekochikhin DIu, Lomonosova AA, Manaa Kh, Kopylov FIu, Syrkin AL. Biomarkers role in the first decompensation of chronic heart failure with preserved left ventricular ejection fraction: 2-year follow-up. Russian Journal of Cardiology and Cardiovascular Surgery. 2017;10(6):46‑51. (In Russ.)
https://doi.org/10.17116/kardio201710646-51

Recommended articles:

References:

  1. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581-2587. https://doi.org/10.1001/jama.290.19.2581
  2. Brouwers FP, de Boer RA, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. European Heart Journal. 2013;34(19):1424-1431. https://doi.org/10.1093/eurheartj/eht066
  3. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. New England Journal of Medicine. 2006;355(3):251-259. https://doi.org/10.1056/nejmoa052256
  4. Mareev VYu, Danielian MO, Belenkov YuN. About the work-group research AGE—O—CHF. Comparative characteristics of patients with CHF, depending on the size of the PV on the results of the Russian multicenter study AGE—O—CHF. Zhurnal Serdechnaya nedostatochnost’. 2006;7(4):164-171. (In Russ.)
  5. Dikur ON, Poltavskaya MG, Giverts IYu, Doletsky AA, Pesheva OV, Syrkin AL. Ventricular-arterial coupling in case of chronic heart failure with preserved and reduced left ventricular ejection fraction. Kardiologiya i serdechno-sosudistaya chirurgia. 2014;4:59-68. (In Russ.)
  6. Fonarow GC. Epidemiology and risk stratification in acute heart failure. American Heart Journal. 2008;155(2):200-207. https://doi.org/10.1016/j.ahj.2006.10.043
  7. Ponikowski P, Voors AA, Anker SD, Bueno H, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2016. https://doi.org/10.1093/eurheartj/ehw128
  8. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
  9. Inker LA, Schmid CH, Tighiouart H, et al Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012 Jul 5;367(1):20-29. https://doi.org/10.1056/NEJMoa1114248
  10. Lam C, Donal E, Kraigher-Krainer E, Vasan RS. F Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(1):18-28. https://doi.org/10.1093/eurjhf/hfq121
  11. Chan MM, et al. How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail. 2013;15(6):604-613.
  12. Melenovsky V, Hwang SJ, Lin G, et al. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J. 2014;35:3452-3562.
  13. Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006;47:742-748. https://doi.org/10.1016/j.jacc.2005.11.030
  14. van Veldhuisen DJ, Linssen GC, Jaarsma T, et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013 Apr 9;61(14):1498-1506. https://doi.org/10.1016/j.jacc.2012.12.044
  15. Kang SH, Park JJ, Choi DJ, et al. Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF. Heart. 2015 Dec;101(23):1881-1888. https://doi.org/10.1136/heartjnl-2015-307782
  16. Schrier RW, Sharma S, Shchekochikhin D. Hyponatraemia: more than just a marker of disease severity? Nature Reviews Nephrology. 2013;9(1):37-50.
  17. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Ren Fail. 2008;30:181.
  18. Huertaa A, Lopezbc B, Ravassab S, et al. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism. Journal of Hypertension. 2016;34:130-138.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.